1354690-24-6 leniolisib

Cov Khoom Siv

Cov tsos dawb kom tawm-dawb crystalline khoom
Cia temp. Khw ntawm -20 degree
solubility DMF: PBS (PBS (PBS (PBS (1) (1): {}}. 5 (mL); mL / mm)
DMOPS: 71.67 (max conc. Mg / ml); 159.09 (max conc. Hli)
Ethanol: 16.5 (max conc. Mg / ml); 36.63 (max conc. Hli)

 

Daim Ntawv Thov:

Leniolisib (CDZ173) yog xaiv Pi3k Δ Inhostitor tsim los ntawm lub tsev muag tshuaj thiab ntawv tso cai los ntawm Novartis. Nws yog tsuas yog siv los kho pi3k Δ Δs overactivation syndrome (APDDS) hauv cov hluas 12 xyoos thiab tau pom zoo rau kev lag luam los ntawm US FDA rau Lub Peb Hlis 24, 2023

 

Cov lus txhais lus:

Leniolisib

1354690-24-6

CDZ173 PUB DAWB

Cdz -173 pa dawb

Cdz 173- nx

leniolisibum

Cdz -173- nx

Cdz173

Leniolisib pub dawb puag

(S) -1- ({}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}, {{9 { } TetrahyDropYROPO [4, {{{11 d] Pyrimidin {} {} -1-}}}}}}}}}}}}}}

{{0 {0}} [(3s) {2}}}}}}} {} {} {} {8}} dih YDRO -5 h-pyrido [4, {4 d] Pyrrimidin {} {} -1-}}}}}}

Cdz -173

1- propanone, 1- ((3s) -3-}}} me nyuam}}} (trifluorethyl ) {{{{{11} pyridinyl) pyrido (4, {13 d) pyrimidin {} {{}} pyrrolidinyl) -

{{0 {0}} ((3s) {2}}}}}}}}}}} {}}, {{1 0}} TetraYDROPYROORO (4, {12}} d) Pyrrimidin {} -1-}}}}}}}

 

 

Cim npe nrov: {{0 {0}} leniolisib, Tuam Tshoj {1354690-24-6 leniolisib Cov Chaw Tsim Tshuaj, Cov Chaw Muag Khoom